SHARE
COPY LINK

COVID-19

EU approves use of Pfizer-BioNTech vaccine in children 12 and over in Europe

The European Commission authorised the use of the Pfizer-BioNTech vaccine in 12- to 15-year-olds on Friday, following the European Medicines Agency's approval of administering the jabs to adolescents earlier in the day.

EU approves use of Pfizer-BioNTech vaccine in children 12 and over in Europe
A nurse prepares a syringe with saline solution before it is diluted with the Pfizer/BioNTech vaccine at the Evonik vaccination in Hanau, western Germany (Photo by THOMAS LOHNES / AFP)

This vaccine is already approved for people aged 16 and over in the EU.

Earlier this month, US regulators authorised the vaccine for children in the 12-to-15 age group, and it is now widely available.

The European Medicines Agency said that two doses of the vaccine would be needed in adolescents and should be given at least three weeks apart, which is the same guidance as for adult use.

Individual EU states would be able to decide whether or not they wanted to offer the vaccine to the 12 to 15-year-olds.

READ ALSO: Vaccines to be made available to children 12 and over in Germany starting June

Germany said on Thursday that it would start giving the vaccine to children from 12 to 15 from June 7th, which is when vaccine prioritisation for all adults is set to end in Germany.

READ ALSO: Covid jabs for children in Germany will be an ‘individual decision’, says Health Minister

Italy has also said it would extend its vaccination campaign to the over-12s, with approval from Italy’s regulator expected by Monday.

READ ALSO: Italy to open Covid jab appointments to all over-16s from June 3rd

And Austrian capital Vienna was waiting for the EMA approval before opening up Covid-19 vaccination registrations to parents of 12- to 15-year-olds.

In Switzerland, meanwhile, children may be able to get vaccinated at the age of 10, even without their parents’ approval.

The EMA approval may help reassure parents when children go back to face-to-face teaching, but the issue is not without controversy.

A few figures in the medical community have said there is not yet enough evidence to support vaccines and their potential side effects in younger people, while others believe older and vulnerable people in less wealthy countries should be prioritised over children.

Member comments

Log in here to leave a comment.
Become a Member to leave a comment.

COVID-19

France scraps compulsory self-isolation after positive Covid test

France's public health body outlined how Covid-19 rules changed starting on February 1st, including an end to compulsory self-isolation after a positive test result.

France scraps compulsory self-isolation after positive Covid test

Starting on February 1st, Covid rules relaxed in France as the country brought an end to compulsory isolation for those who test positive for the virus.

However, those travelling from China to France will still be required to agree to a random screening upon arrival and to isolate in the case of a positive Covid-19 test result. Travellers aged 11 and over coming from China must also provide a negative test result (less tan 48 hours) prior to boarding and those aged six and over must agree to wear a mask on board flights. These regulations – which was set to last until January 31st – is set to remain in place until February 15th.

The French public health body (The Direction générale de la santé or DGS)  announced the change on Saturday in a decree published in the “Journal Officiel” outlining the various ways the body will loosen previous coronavirus restrictions.

READ MORE: What Covid rules and recommendations remain for visiting France?

Those who were in contact with someone who tested positive – ie a contact cases – will also no longer be required to take a test, though the public health body stressed that both testing after contact and isolating after receiving a positive test remain recommended.

Previously, even asymptomatic people who had been in contact with someone who tested positive for Covid-19 were required to test on the second day after being notified that they were a “contact-case”.

These changes took effect on February 1st.

READ MORE: What changes in France in February 2023?

The DGS also said that website SI-DEP, which records test results, will remain in operation until June 30th, however starting in February it will only collect personal data with the express permission of the patient.

Manual widget for ML (class=”ml-manual-widget-container”)

Additionally, the French government announced that sick leave procedures for people with Covid-19 would return to normal starting February 1st – this means that those who test positive for Covid-19 now also have the three-day wait period before daily sick benefits are required to be paid, as is usually the case. Previously, people with Covid-19 could expect daily sick benefits to begin at the start of their sick leave period (arrêt maladie in French).  

READ MORE: How sick leave pay in France compares to other countries in Europe

Covid tests are still available on walk-in basis from most pharmacies are are free to people who are fully vaccinated and registered in the French health system. Unvaccinated people, or visitors to France, have to pay up to a maximum of €22 for an antigen test of €49 for a PCR test. 

If you recently tested positive for Covid-19 in France – or you suspect you may have contracted Covid-19 – you can find some information for how to proceed here.

In explaining the changes that began at the start of February, the French public health body also noted a drop in Covid-19 infections in the past month. As of January 30th, approximately 3,800 people in France had tested positive in the previous 24 hours for the coronavirus – which represents a decrease from the averages of 20,000 new cases per day about one month ago.

SHOW COMMENTS